Showing results (1-10 of 48) with videos related to

Sort By:
Pageof 5
Molecular Cancer Therapeutics|May 17, 2008
An experimental and theoretical evaluation of the influence of pretargeting antibody on the tumor accumulation of effectorGuozheng Liu, Shuping Dou, Mary Rusckowski, et al.
Applied Radiation and Isotopes : Including Data, Instrumentation and Methods for Use in Agriculture, Industry and Medicine|April 3, 2010
Preparation of (111)In-DTPA morpholino oligomer for low abdominal accumulationGuozheng Liu, Shuping Dou, Mary Rusckowski, et al.
Cancer Biotherapy & Radiopharmaceuticals|March 9, 2013
Intraperitoneal injection is not always a suitable alternative to intravenous injection for radiotherapyShuping Dou, Miles Smith, Yuzhen Wang, et al.
Nuclear Medicine and Biology|May 17, 2008
Investigation of four (99m)Tc-labeled bacteriophages for infection-specific imagingMary Rusckowski, Suresh Gupta, Guozheng Liu, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|July 6, 2004
Investigations of a (99m)Tc-labeled bacteriophage as a potential infection-specific imaging agentMary Rusckowski, Suresh Gupta, Guozheng Liu, et al.
Cancer Biotherapy & Radiopharmaceuticals|September 7, 2007
Evidence of specificity of radiolabeled phage display peptides for the TAG-72 antigenMary Rusckowski, Suresh Gupta, Guozheng Liu, et al.
Bioconjugate Chemistry|March 28, 2007
An improved method for covalently conjugating morpholino oligomers to antitumor antibodiesJiang He, Guozheng Liu, Shuping Dou, et al.
Nucleosides, Nucleotides & Nucleic Acids|January 27, 2015
A feasible approach to evaluate the relative reactivity of NHS-ester activated group with primary amine-derivatized DNA analogue and non-derivatized impurityShuping Dou, John Virostko, Dale L Greiner, et al.
European Journal of Nuclear Medicine and Molecular Imaging|October 6, 2006
Predicting the biodistribution of radiolabeled cMORF effector in MORF-pretargeted miceGuozheng Liu, Shuping Dou, Jiang He, et al.
Pageof 5